NSEGeneral Updates12h ago · 1 Sept 2026, 03:49 pm
General Updates
Gland Pharma Limited · GLAND
✦ AI SummaryRegulatory
Gland Pharma Limited has informed the Exchange about General Updates regarding the United States Food and Drug Administration (USFDA) inspection at its Visakhapatnam facility between August 2022 and September 2022, which was conducted with zero observations.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Limited has informed the Exchange about General Updates